Print Preview Area

Nephrogenic Systemic Fibrosis
American Journal of Roentgenology, 06/29/2012

Kaewlai R et al. – Nephrogenic systemic fibrosis (NSF) is a potentially lethal disorder that occurs in patients with reduced kidney function. Current evidence suggests a strong association with gadolinium–based contrast agents—mostly used in MRI—in this patient group. This has urged the radiology community to emphasize careful screening for the presence of renal dysfunction among patients for whom gadolinium–enhanced MRI is contemplated. Appropriate selection of gadolinium–based contrast agent type, avoidance of nonstandard dosage, patient education, and informed consent have been recommended by authorities.

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Stay current on the latest literature, research and clinical news
Get special communications and offers from MDLinx and our sponsors
Receive invitations to paid market research

View Samples and Register

Stay current - Media Tool

Newsletter

RSS

Facebook

Receive free subspecialty
"5-minute updates" via email

Send the E-mail Newsletter to a Colleague

♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦

♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦

♦ Follow Us on Facebook

Search the latest
Physician Assistant Jobs
@MDLinx Career Center
View the full listing of physician jobs

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Nephrogenic Systemic Fibrosis American Journal of Roentgenology, 06/29/2012

Nephrogenic Systemic Fibrosis
American Journal of Roentgenology, 06/29/2012